CompletedNot Applicable

Comparison of AMCOP Bioactivator and High-pull Headgear in Treating Skeletal Class II Hyperdivergent Pediatric Patients

Italy40 participantsStarted 2024-03-03

Plain-language summary

The aim of the present study was to retrospectively compare the clinical use of high-pull headgear versus AMCOP bioactivators for hyperdivergent pediatric patients. Cephalometric radiographs from pediatric patients treated at the Unit of Orthodontics and Pediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy and at the private practice of Dr. Cardarelli, Isernia, Italy will be collected. Cephalometric tracing from Giannì analysis will be performed at the baseline (T0) and after 18 months of treatment (T1).

Who can participate

Age range7 Years – 11 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * mixed or permanent dentition * skeletal class II malocclusion diagnosed with ANB angle \> 4° from cephalometric radiograph * skeletal hyperdivergency calculated from AnsPns\^GoGn angle \> 25°, and at least S-Ar\^Go \> 149° or Ar-Go\^Gn \> 137° Exclusion Criteria: * lack of compliance in the use of the orthodontic appliance * syndromic patients, cleft lip or cleft palate, severe malformations and asymmetries of the jaws.

What they're measuring

Change in cephalometric angular measurements

Timeframe: Baseline (T0) and after 18 months (T1)

Linear regressions

Timeframe: Baseline (T0) and after 18 months (T1)

Change in cephalometric linear measurements

Timeframe: Baseline (T0) and after 18 months (T1)

Trial details

NCT IDNCT06281613

SponsorUniversity of Pavia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-26

View on ClinicalTrials.gov More Skeletal Malocclusion trials